· AIM:Tocomparetheeffectsofthiaminepyrophosphate (TPP)andthiamine(TM)inoxidativeopticneuropathyin ratsinducedbyethambutol.
.Therefore,ethambutol usuallyisrequiredforuseagainstmosttuberculosisstrains. However,sideeffectsobservedduringethambutoltherapy remainoneofthemostimportantcausesoftreatment discontinuation.Althoughsideeffectssuchasperipheral nervoussystemdisease,thrombocytopeniaandhepatotoxicity areseenwithethambutoluse [2] [3] [4] ,itsmostimportantsideeffect isopticneuropathy.Ethambutolhasadversesideeffectson peripheralnervoussystemdisease,thrombocytopenia,and hepatotoxicity [2] [3] [4] ,butmainlyonneuropathy [5] .Optic neuropathysymptomsdevelopmonthsafterinitiationofthe treatment [6] .However,emergingtoxicneuropathiesafter takingethambutolalsohavebeenreported [7] .Studieshave demonstratedthatopticneuropathymight occurwith ethambutoltreatmentevenatlowdoses [7] [8] .Opticneuropathy connectedwithethambutolhasbeenreportedtodose dependentlyrangefrom3%-10% [9] .Thisdemonstratesthat thetoxicityofethambutolintheopticnerveisselective [10] .Sahin [11] reportedthatexperimentallyadministeredethambutol increasestheamountofmalondialdehyde(MDA),alipid peroxidationproductintheopticnervethatdecreasesactivity oftheendogenousantioxidantsuperoxidedysmutase(SOD), producingoxidativedamage,whereasNebbioso [12] reportedthatoxidativeinjuryoftheopticnervecanbe treatedwithantioxidants.Aditionally,Cinici [14] [15] . ThiscausesthereductionofactivityofTM.Therefore,TPP comparedwithTMactivitywasevaluated.Thestudyalso evaluatedtherelationshipbetweentheinhibitionofTPKand thetoxiceffectsofethambutolontheopticnerve.Thisstudy investigatedtheprotectiveeffectsofTPPagainstoptic neuropathyinducedwithethambutol,anactiveformofTM [16] . TPPwasdemonstratedtoprotectthetissueagainstoxidative stressbydecreasingtheamountofoxidantincreaseand alterationofendogenousantioxidants [17] .Ithasbeenreported inapreviousstudythatethambutolcausesdamageinretinal tissue,increasingoxidantparametersandreducing antioxidantparameters.Also,TPPinhibitstheethambutolinducedoxidativeretinaldamage,whileTMdoesnot,as evidencedbythehistopathologicalfindings [13] .Thissuggests TPPmaybeusefulinpreventionandtreatmentofoxidative opticneuropathyduetoethambutol.Resultsshowedthat MDAgeneexpressionincreasedandGSHgeneexpression decreasedinratopticnervetissuesadministeredwith ethambutolcomparedtohealthytissue.Ithasbeenreported thatethambutolincreasesMDAandtotaloxidantcapacity butdecreasestheantioxidantcapacityintheopticnerve tissueofanimals [11] .Ethambutolincreasestheamountof MDAandreducestheamountofGSHintheretinaltissue [13] . Theliteraturereviewandresultsofthisstudyindicatethat oxidativestressdevelopsintheopticnervetissueofthe ethambutol-administeredanimals.AccordingtoWilliams [18] , oxidativestressplaysaroleinthepathogenesisofmany eye-disease'sstresssuchasconjunctiva,cornea,uvea inflammation,lenscataract,glaucoma,andopticneuritis. Izzotti [19] suggestedthatopticnervedamageresultfrom oxidativestress.Opticneuropathyisawell-known complicationofethambutoltherapy [20] andseveralstudiesin theliteraturehavedemonstratedthatantioxidantssuchas N-acetylcysteineandSODareusefulinthepreventionof oxidativeinjuryintheopticnerve [12] . Inourstudy,theMDAandGSHexpressionlevelsforthe TPPGgroupwereclosesttotheCGgroup,andmild vacuolizationwasobservedintheopticnervetissue. However,markedvacuolization,single-cellnecrosisinglial cellsandoligodendrocytesdecreasewereobservedinthe TMGandETCgroups,havinghighMDAandlowGSHgene expressions.Thereareseveralstudiesshowingthesignificant vacuolizationinopticnervedamage [21] .Also,some experimentalstudieshavedemonstratedthatvacuolization maybecausedbythetoxiceffectsofmedications [22] .Zubair [23] histopathologicallydemonstratedthatvacuolization developsintheopticnerveofehtambutol-administered animalsshowninvacuolizationcausedbyethambutolin retinaltissue [24] .Againsingle-cellnecrosiswasfoundinglial cellsoftheTMGandETCgroups,whilesingle-cellnecrosis was notobservedintheTTPadministeredanimals. Single-cellnecrosisdevelopedintheopticnerveinducedby ethambutol,consistentwiththeliterature.Thesamefinding wasreportedbyKinoshita [25] .Thenegativeeffectof ethambutolonglialcellswasdeterminedbyGongand Amemiya [26] ,itwasexpressedasthecauseofthereductionof zinc.Inaddition,TTP preventedadecreasein oligodendrocytescausedbyethambutol.Itisunderstoodfrom somestudiesthatoxidativestressplaysaroleinpathogenesis decreaseinoligodendrocytes [27] .Inastudyconductedby El-Sayyad [28] withanimals,demyelinationdecreasein oligodendrocytesandastrocyteswerearguedtobearesultof oxidativestress.Asisknown,theastrocytesareatypeof glialcellandthemyelinisproducedbyoligodendrocytes. Thisinformationfromtheliteratureisconsistentwithour histopathologicalresults.Theliteraturereportsthatoxidative stressinoligodendrocytesdependsontheuseofethambutol orB-groupvitamindeficiency [29] .Thisisconsistentwithour experimentalresults.Inourstudy,wedeterminedthatthe TPPprotectsagainstthetoxiceffectsofethambutolonthe opticnervetissue,butTMdoesn'tprotect.Thepreviousstudy showedthattheTPPprotectsagainstthetoxiceffectsof ethambutolontheretinaltissue,butTMwasunableto protect [13] .Asisknown,TMcannotenoughtransformation toTPPincellsleadstothefunctionsandorganicdisordersin thetissue [30] .IntheTTPdeficiency,pyruvateandlacticacid accumulatesinthebloodandtissues [31] .Theaccumulationof lacticacidandpyruvateleadstotissuedamageintheeye's retinatissue [32] .AccordingtoPolat [15] ,TPPprevented oxidativedamageinducedbydoxorubicin,whileTMcould not;inaddition,itwasarguedinthesamestudythat doxorubicinpreventedTPPproductionbyinhibitionofthe enzymeexpressionofTPKandtherefore, externally administeredTMcouldnotpreventcardiotoxicitycausedby doxorubicin.Itwasstatedagaininanotherstudythat, althoughnormallevelsofTMwerefoundintheblood,TM deficiencyindicationsinthetissuealsomaybeseen [33] .This informationsuggeststhatethambutolmightleadtoadecrease inTPPproductionandneuropathyinopticnervetissueby inhibitionofTPKenzymeactivitysinceitisarguedthat somemedicationsinhibitTPK,preventingitsconversion toTPP,anactiveformofTMandleadtovitamin deficiency [14, [34] [35] .Inthefuturethisstudywillbeexaminewith moreanimalsandmoredetailedbyaddingtheERGand electronmicroscopyevaluation. Inconclusion,oxidativedamageinratopticnervescausedby ethambutolwasdemonstratedbasedontheMDAandGSH geneexpressionandhistopathologicalfindings.TPPwas understoodtoprotectopticnervetissueagainstthetoxic effectofethambutol.However,TMcouldnotprotectthe opticnerveagainstthetoxicityofethambutol.Therefore,itis thoughtthatTPPmaybeusefulinopticneuropathycaused byethambutol. However,inordertoexplainwhythepresenceofTMis ineffectiveagainstethambutoltoxicity,detailedresearch shouldbeperformedlatertodeterminetheethambutolinhibitoryeffectontheTPKenzyme.
